AIA (n = 19) | ATA (n = 21) | Healthy (n = 30) | p Value | |||
AIA vs ATA | AIA vs HC | ATA vs HC | ||||
Urinary PGE2-M (pg/mg creatinine) | 477.1 (277.69) | 480.7 (222.1) | 879.47 (210.78) | 0.95 | 0.88 | 0.72 |
464 (281–600) | 451 (342–538) | 403.5 (303–763) | ||||
Urinary tetranor-PGE-M (ng/mg creatinine) | 11.05 (9.64) | 10.27 (7.83) | 10.06 (8.43) | 0.79 | 0.96 | 0.87 |
7.2 (5.4–11.1) | 7.9 (5.0–12.4) | 7.6 (4.9–10.5) | ||||
Urinary LTE4 (pg/mg creatinine) | 1846.6 (2747.4) | 342.0 (277.7) | 257.0 (180.2) | <0.001 | <0.001 | 0.75 |
1347 (355–2036) | 220 (160–361) | 222 (119–315) |
Values are expressed as mean (SD) and median (25–75% percentiles).
AIA, aspirin-induced asthma; ATA, aspirin-tolerant asthma; PGE2-M, 13,14-dihydro-15keto-PGE2; tetranor-PGE-M, 9,15-dioxo-11α-hydroxy-2,3,4,5-tetranor-prostan-1,20-dioic acid; LTE4, leucotriene E4.